DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...
Cellular Origins reports that the company completed the first phase of its collaboration with Fresenius Kabi designed to help scale the manufacturing of cell and gene therapies using advanced robotics ...
CAMBRIDGE, England & BAD HOMBURG, Germany--(BUSINESS WIRE)--Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that ...
CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters." Cell processing revenue ...
CEO Roderick de Greef highlighted strong quarterly performance, stating that "cell processing revenue increased 33% year-over-year, driving a 31% increase in total revenue for the quarter." He ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results